AREV Life Sciences Global Corp.

CNSX: AREV


Canadian symbol: AREV.CN
US symbol: AREVF

Currency in CAD

Valuation Measures4

Market Cap (intraday) 3.57M
Enterprise Value 3.62M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.97
Price/Book (mrq)1.86
Enterprise Value/Revenue 16.36
Enterprise Value/EBITDA -4.77

Trading Information

Stock Price History

Beta (5Y Monthly) 2.06
52-Week Change 3-41.86%
S&P500 52-Week Change 3-11.08%
52 Week High 30.3900
52 Week Low 30.0800
50-Day Moving Average 30.1792
200-Day Moving Average 30.2270

Share Statistics

Avg Vol (3 month) 34.55k
Avg Vol (10 day) 38.34k
Shares Outstanding 528.53M
Implied Shares Outstanding 6N/A
Float 816.14M
% Held by Insiders 169.09%
% Held by Institutions 10.00%
Shares Short (May 12, 2022) 4642
Short Ratio (May 12, 2022) 40.19
Short % of Float (May 12, 2022) 4N/A
Short % of Shares Outstanding (May 12, 2022) 40.00%
Shares Short (prior month Apr 13, 2022) 4450

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Mar 18, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-723.50%

Management Effectiveness

Return on Assets (ttm)-127.34%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)221.03k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-79.70%
Gross Profit (ttm)N/A
EBITDA -1.52M
Net Income Avi to Common (ttm)-933.94k
Diluted EPS (ttm)-0.0440
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.05k
Total Cash Per Share (mrq)0
Total Debt (mrq)68.05k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.15
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-1.14M
Levered Free Cash Flow (ttm)-480.86k

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen



Warning: Use of undefined constant SITE_CONFIG_TWITTER_ACCOUNT - assumed 'SITE_CONFIG_TWITTER_ACCOUNT' (this will throw an Error in a future version of PHP) in /var/www/vhosts/shroominvestor.com/httpdocs/web/app/themes/15zine-child/module-stock-news.php on line 10



Notice: Undefined variable: current_category_name in /var/www/vhosts/shroominvestor.com/httpdocs/web/app/themes/15zine-child/module-stock-news.php on line 247

Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.


Notice: Undefined index: newsCategory in /var/www/vhosts/shroominvestor.com/httpdocs/web/app/themes/15zine-child/module-stock-news.php on line 363

Notice: Undefined index: stockNewsCategory in /var/www/vhosts/shroominvestor.com/httpdocs/web/app/themes/15zine-child/module-stock-news.php on line 363



Company News Date
AREV.CN
AREV Life Sciences Global
AREV.CN
AREV Life Sciences Global
AREV.CN
AREV Life Sciences Global

Notice: Undefined index: newsCategory in /var/www/vhosts/shroominvestor.com/httpdocs/web/app/themes/15zine-child/module-stock-news.php on line 710


Notice: A non well formed numeric value encountered in /var/www/vhosts/shroominvestor.com/httpdocs/web/functions_stocks.php on line 626
Analysts data is not available

Notice: Undefined variable: insiders_html in /var/www/vhosts/shroominvestor.com/httpdocs/web/app/themes/15zine-child/template-company-details.php on line 711


Insiders transactions are updated every hour.

Notice: A non well formed numeric value encountered in /var/www/vhosts/shroominvestor.com/httpdocs/web/functions_stocks.php on line 626

Major Holders

Currency in CAD
Breakdown
69.09%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by AREV Life Sciences Global Corp.


Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs

The partnership will help serve a dire need for surface disinfectant treatments to prevent the spread of highly infectious diseases to vulnerable populations in developing nationsVANCOUVER, British Columbia, June 03, 2021 -- AREV Nanotech Brands, Inc. (CSE:AREV) (CNSX:AREV.CN) (OTC:AREVF) ("AREV" or the “Company"), a publicly traded life ... Read More...

AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins For Use in Its Ready-To-Use Therapeutic Foods

VANCOUVER, British Columbia, June 16, 2021 -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) Through its subsidiary AREV Cambodia is pleased to announce the Company has completed its land survey and soil analysis for cultivation of mushrooms, moringa and breadfruit.Mr. Rem Sareub, Head of Agriculture for AREV ... Read More...
Coming Soon.

Notice: A non well formed numeric value encountered in /var/www/vhosts/shroominvestor.com/httpdocs/web/functions_stocks.php on line 626
IndexLast% Change
S&P 5003,812.57

0.23%Negative

Euro STOXX 503,512.44

1.04%Negative

FTSE 1007,313.78

0.13%Negative

Nikkei 22526,804.60

0.91%Negative


Delayed data (1h)

Notice: A non well formed numeric value encountered in /var/www/vhosts/shroominvestor.com/httpdocs/web/functions_stocks.php on line 626
IndexLast% Change
S&P 5003,812.57

0.23%Negative

Euro STOXX 503,512.44

1.04%Negative

FTSE 1007,313.78

0.13%Negative

Nikkei 22526,804.60

0.91%Negative



Share this page